NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Investing
Should You Buy Aurora Cannabis Inc. (TSX:ACB) or Tilray Inc. (NASDAQ:TLRY) Stock Right Now?
Investing
Marijuana Stocks: Is the Latest Crash in Pot Stocks a Buying Opportunity?

Investing
Pot Legalization Has Landed: What to Expect in the Markets

Investing
Cannabis Analyst Warns of Bitcoin-Like Bubble in Pot Stocks like Tilray Inc (NASDAQ: TLRY)

Investing
Why Aurora Cannabis Inc. (TSX:ACB) Stock Could Soon Take Off Like Tilray (NASDAQ:TLRY)!

Investing
Canopy Growth Corp (TSX:WEED) vs. Tilray Inc (NASDAQ:TLRY): Which Is the True Cannabis King?

Investing
Will Tilray Inc. (NASDAQ:TLRY) Knock Canopy Growth Corp. (TSX:WEED) From the Canopy?
Investing
Are Investors Smoking Something? Top 9 Canadian Pot Stocks Now Worth Half of Canada’s Entire Tech Sector!
Investing
Why Canopy Growth Corp. (TSX:WEED) Isn’t Immune From a Cannabis Collapse Despite Being Best-in-Breed
Top TSX Stocks
Canopy Growth Corp (TSX:WEED) (USA) vs. Aurora Cannabis Inc (TSX:ACB): Which Is the Better Buy Ahead of Legalization?
